<DOC>
	<DOC>NCT01051479</DOC>
	<brief_summary>The purpose of this study is to evaluate the investigators ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer.</brief_summary>
	<brief_title>A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Newly diagnosed or recurrent patients with locally advanced esophageal cancer with either squamous or adenocarcinoma histology. Ability to tolerate PET imaging Prior malignancy is allowed, but the expectation of survival must be that beyond that expected for patients with locally advanced esophageal cancer. Pregnant or lactating females are not eligible for this pilot study. Patients having received chemotherapy in the 3 months prior to registration for any reason Patients with metastatic disease requiring chemoradiation for palliation are not allowed.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>PET Positron emission tomography</keyword>
	<keyword>CT X-ray computed tomography</keyword>
	<keyword>Patients with Locally Advanced Esophageal Cancer</keyword>
</DOC>